ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 121 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,725,000 | +3.7% | 1,181,899 | +0.9% | 0.00% | – |
| Q4 2016 | $1,663,000 | -15.9% | 1,171,453 | +3.7% | 0.00% | -100.0% |
| Q3 2016 | $1,977,000 | +1.2% | 1,129,645 | -1.1% | 0.00% | 0.0% |
| Q2 2016 | $1,953,000 | -12.6% | 1,141,792 | +0.7% | 0.00% | 0.0% |
| Q1 2016 | $2,234,000 | +3.9% | 1,134,107 | +0.2% | 0.00% | 0.0% |
| Q4 2015 | $2,150,000 | -1.9% | 1,131,385 | -1.3% | 0.00% | 0.0% |
| Q3 2015 | $2,191,000 | -67.0% | 1,146,699 | -19.9% | 0.00% | -50.0% |
| Q2 2015 | $6,641,000 | +14.3% | 1,431,187 | +7.6% | 0.00% | 0.0% |
| Q1 2015 | $5,812,000 | +41.3% | 1,329,976 | +12.2% | 0.00% | +100.0% |
| Q4 2014 | $4,112,000 | -20.1% | 1,185,265 | -3.5% | 0.00% | 0.0% |
| Q3 2014 | $5,145,000 | -65.1% | 1,227,825 | -51.1% | 0.00% | -50.0% |
| Q2 2014 | $14,724,000 | +86.6% | 2,512,380 | +100.6% | 0.00% | 0.0% |
| Q1 2014 | $7,892,000 | +8.2% | 1,252,669 | +0.4% | 0.00% | 0.0% |
| Q4 2013 | $7,296,000 | -44.8% | 1,247,205 | -50.2% | 0.00% | 0.0% |
| Q3 2013 | $13,210,000 | +41.7% | 2,506,660 | +107.1% | 0.00% | -33.3% |
| Q2 2013 | $9,320,000 | – | 1,210,368 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
| Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
| Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
| FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
| OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
| NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
| MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |